Competition Act claim alleges that Canadians are being overcharged for prescription drugs Competition Act claim alleges that Canadians are being overcharged for prescription drugs
  • The Firm
  • Our Litigation
  • Our News
  • Contact Us
  • The Firm
  • Our Litigation
  • Our News
  • Contact Us

2014

Competition Act claim alleges that Canadians are being overcharged for prescription drugs

Morganti Legal and McKenzie Lake Lawyers LLP, are representing Canadian pharmacies and consumers that allege that Pfizer Canada Inc abused the Canadian patent system in order to obtain exclusive rights in Canada to sell the pharmaceutical drug pregabalin sold under the trade name Lyrica. Pfizer’s activities resulted in it enjoying 100% of the Canadian market…

Read More
Canadian Hedge Fund Researcher Sues Silvercorp Over False Imprisonment in China

A researcher for a Canadian hedge fund manager who claimed that ore estimates at a Chinese Mine owned by Silvercorp Metals were overstated and misrepresented has filed a lawsuit accusing the mining company of conspiring with Chinese authorities to have him arrested and detained. Kun Huang was stopped at the Bejing airport by Chinese authorities in…

Read More
Morganti Legal, P.C.: Canadian Shareholder Files A Lawsuit Against Allied Nevada Gold Corporation

TORONTO–(BUSINESS WIRE)–Morganti Legal, P.C., announces that investors have filed a shareholder lawsuit against Allied Nevada Gold Corporation (TSX: “AVN”) for publishing press release containing alleged Misrepresentations and failing to disclose Material Facts about its business operations concerning its Lewis Leach Pad between January 18, 2013 and August 5, 2013. The investors’ mining expert has been…

Read More
Shareholders allege that Detour Gold Corporation made Misrepresentations

Morganti Legal, P.C., (May 12, 2014) announces that investors have filed a shareholder lawsuit against Detour Gold Corporation (“Detour Gold” or the “Company”) (TSX: “DGC”) for publishing press releases containing alleged misrepresentations and failing to disclose Material Facts about its business operations between April 9, 2013 and November 7, 2013. The investors’ mining experts have…

Read More
Andrew Morganti Lectures at the University of Michigan School of Law

Tuesday, February 18, 2014 Cy Moscow, partner of leading Detroit-based law firm Honigman Miller Schwartz & Cohn LLP, and adjunct professor at University of Michigan School of Law, has invited Andrew Morganti to lecture to third-year students in his advanced securities regulations course on the topic of shareholders’ rights litigation from the perspective of the…

Read More
Ontario Court of Appeal Upholds Access to Justice by Clarifying the Limitations Period for Investors to Seek Damages Against Companies

Tuesday Feb 4, 2014 On February 3, 2014, the Ontario Court of Appeal released its decision in three shareholder class proceedings claiming damages under Part XXIII.1 of the Securities Act(1) for misrepresentations alleged to have been made in respect of shares trading in the secondary market. In Green v. CIBC(2) , a specially convened five-judge panel unanimously…

Read More

Recent News

  • MORGANTI & CO., P.C. x KIM SPENCER MCPHEE BARRISTERS P.C.
  • Quebec courts recognize investors’ allegations of insiders manipulating stock prices
  • “You can’t handle the truth!”
  • Investment Banks’ Responsibilities: Court of Appeal for Ontario endorses claim
  • Former Newstrike Brands Ltd. investors lodge claim against HEXO CORP.
Morganti & CO., P.L.C. (Michigan, United States)

Disclaimer / Terms of Use
Morganti & CO., P.C. (Ontario, Canada)
Register

    For the shares purchased during the identified "class period", those shares are automatically considered to be included within the proceeding. For shares purchased outside of the identified "class period", those are not automatically included and you may be required to retain your own lawyer.

    We welcome you to complete the below form so you can receive future updates about the proceeding. If you invested more than $100,000, in the particular investment, please complete the form and we will contact you within the near future.